Pluri Inc. — Director's Dealing 2010

Aug 12, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2010-08-12

Reporting Person: Aberman Zami (Director, CEO & Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-08-12	Common Stock	A	200000	—	Acquired	739151	Direct

Footnotes

F1: The shares vest upon meeting certain clinical milestones.